Andrew Brackin invests in vertical AI, healthcare, and application software as a partner at Gradient. A 2013 Thiel Fellow, he previously co-founded clinical-trial technology company Vial and was the founding head of growth at Newfront.

Claimed by the subject

Andrew Brackin invests in vertical AI, healthcare, and application software as a partner at Gradient. A 2013 Thiel Fellow, he previously co-founded clinical-trial technology company Vial and was the founding head of growth at Newfront.

Career

Andrew Brackin studied at Thiel Fellowship (Fellow, 2013–2015).

Partner at Gradient Ventures from 2024 to Present

Investing Announcements

gradient.com

The Clinical Intelligence Layer for Medicine with Vera Health

How clinical AI can earn physicians’ trust through evidence quality, specialty context and auditable sources.

Open ↗

Andrew's Collections

Andrew's Lists

In these lists

Cosigns Given